Innovative medical equipment manufacturer Mindray has introduced next-generation BeneHeart series defibrillators, the BeneHeart D60 and D30, to the UK. The new device aims to raise the standards for resuscitation and defibrillation, providing fast diagnosis in emergency rescue situations.
According to the Resuscitation Council UK, the annual incidence of in-hospital cardiac arrest is 1 to 1.5 per 1,000 hospital admissions. There are also more than 30,000 out-of-hospital cardiac arrest incidents every year with a survival rate of less than 1 in 10.1 Early CPR and defibrillation can more than double the chances of survival in some cases. This makes the combination of highly trained medical staff and efficient, effective equipment crucial, especially for identifying hidden trauma and informing hot debriefings when a patient isn’t responding to CPR.
NHS standard contracts state that patients arriving at an emergency department by ambulance must be handed over to the care of A&E staff within 15 minutes2. This, added to the already intense pressure on the provision of potentially life-saving care, means A&E staff need 100% confidence in the tools at their disposal.
“Defibrillators play a critical role in reducing all-cause mortality and emergencies. We believe that through upgrading first-aid diagnosis and treatment tools and introducing comprehensive rescue quality improvement schemes, prompt, correct, and high-quality medical interventions can save patients’ lives and improve their quality of life,” comments Paul Bailey, General Manager, Mindray UK.
The BeneHeart defibrillators are designed to provide emergency rescuers with more comprehensive information on the scene. This live patient data is then shared with emergency departments and hospitals via digital workflows so clinical teams can prepare for arrivals and provide the best possible care. In essence a complete quality improvement solution for both pre-hospital and in-hospital rescue allowing advanced treatment planning that can save lives.
The Mindray BeneHeart D60 has multiple diagnosis and analysis functions so rescuers have a more holistic picture on patient status even in complex pre-hospital environments. Professional 12-lead ECG analysis functions with intelligent assistance help to efficiently diagnose chest pain conditions and identify myocardial infarction locations, whilst a 6-channel recorder generates real-time ECG reports.
The D60 is the first defibrillator of its kind to incorporate point-of-care ultrasound for accurate and confident decision-making by providing step-by-step identification tools, operation guides, and reference images. This latest technology guides the user through ultrasound to ensure H’s and T’s during cardiac arrest are ruled out.
The D30 and D60 are the first defibrillator to incorporate patented non-invasive CQI (care quality index) technology that illustrates blood blow in cardiac arrest. Resuscitation Teams can now accurately comment of efficiency of chest compressions and ROSC (return of spontaneous circulation) without the needed for invasive technologies.
There are several upgrades to note on both units that improve ease of use and reliability. The high-definition capacitive touch screen allows for increased operational efficiency, whilst actual dials and buttons can be used for critical procedures. Weighing only 4.2kg with battery, the defibrillators are water and dust-proof and incorporate a drop-protection design with the ability to operate in temperatures ranging from -20°C to 55°C.
Equipped with patented QShockTM technology, the units have a turn on time of just two seconds and charge to 200 joules in three seconds with an ability to escalate to 360 joules. This, along with filtered ECG analysis technologies, provides faster defibrillation and a comprehensive CPR evaluation system to monitor real-time CPR performance, with instant feedback for clinicians.
The new BeneHeart defibrillators empower structured debriefing that support automatic rescue data recording for hot debriefing. The capabilities for connectivity help resuscitation teams improve CPR and defibrillator operation through audit and cold debriefing.
The technologies and features of these new defibrillators incorporate Mindray’s ‘Rescue Triangle’ concept where all-round resuscitation covers the whole clinical process from resuscitation to debriefing and training.
Fast diagnosis in all emergency situations will bring increased resuscitation rates. Reliable, trusted, smart technology is the answer.
Mindray is a leading global developer of medical devices, with an R&D network spanning the US, Europe, and China. With a local focus on patient monitoring and ultrasound in the UK, Mindray provides innovative medical devices to a range of hospital departments, including emergency, perioperative and critical care.
For further information visit: www.mindrayuk.com